• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Beauty Health Company filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    6/17/25 4:03:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care
    Get the next $SKIN alert in real time by email
    skin-20250612
    FALSE0001818093Nasdaq00018180932025-06-122025-06-120001818093us-gaap:CommonStockMember2025-06-122025-06-12

     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549  
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): June 12, 2025
     
    The Beauty Health Company
    (Exact name of registrant as specified in its charter)  
     
    Delaware 001-39565 85-1908962
    (State or other jurisdiction
    of incorporation)
     
    (Commission
    File Number)
     
    (IRS Employer
    Identification No.)
    2165 Spring Street
    Long Beach, CA
    (Address of principal executive offices)

    90806
    (Zip Code)
    (800) 603-4996
    (Registrant’s telephone number, including area code)
    Not Applicable
    (Former name or former address, if changed since last report)
     
    Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class 
    Trading
    Symbol(s)
     
    Name of each exchange
    on which registered
    Class A Common Stock, par value $0.0001 per share SKIN 
    The Nasdaq Capital Market
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
    Emerging growth company  ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐  
     



    Item 5.07. Submission of Matters to a Vote of Security Holders.

    On June 12, 2025, The Beauty Health Company (the "Company") held its annual meeting of stockholders (the "Annual Meeting") in a virtual format. At the close of business on April 16, 2025, the record date for the Annual Meeting (the "Record Date"), there were 125,989,795 shares of the Company’s Class A Common Stock, par value $0.0001 per share ("Class A Common Stock") issued and outstanding, which constituted all of the issued and outstanding capital stock of the Company as of the Record Date. At the Annual Meeting, 98,779,565 of the Company’s 125,989,795 outstanding shares of Class A Common Stock entitled to vote as of the Record Date, or approximately 78.40%, were represented by proxy or in person (virtually), and, therefore, a quorum was present.

    The three proposals voted on at the Annual Meeting are more fully described in the Definitive Proxy Statement on Schedule 14A filed by the Company with the Securities and Exchange Commission on April 25, 2025 (the "Proxy Statement").

    The final voting results on the proposals presented for stockholder approval at the Annual Meeting are as follows:

    Proposal No. 1: Election of Seven Directors

    The Company’s stockholders elected the seven directors listed below, each to serve for a term of one year, expiring at the Company's 2026 annual meeting of stockholders or until his or her successor is duly appointed or elected and qualified or until his or her earlier death, resignation, or removal from office, as follows:

    Nominees
    Votes
    For
    Votes
    Withheld
    Broker Non-Votes
    Marla Beck
    85,418,8852,520,77210,839,908
    Brenton L. Saunders
    80,051,0867,888,57110,839,908
    Doug Schillinger70,559,79417,379,86310,839,908
    Stephen J. Fanning86,504,1851,435,47210,839,908
    Brian Miller
    64,343,79923,595,85810,839,908
    Desiree Gruber69,656,57118,283,08610,839,908
    Michelle Kerrick81,500,6156,439,04210,839,908

    Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm

    The Company’s stockholders ratified the appointment of Deloitte & Touche LLP as the Company’s independent, registered public accounting firm for the fiscal year ending December 31, 2025, as follows:

    Votes For
    Votes
    Against
    Abstentions
    Broker Non-Votes
    98,627,630102,14149,7940


    Proposal No. 3: Advisory Vote on the Compensation of the Named Executive Officers

    The Company’s stockholders approved, on an advisory, non-binding basis, the compensation paid by the Company to its named executive officers as disclosed in the Proxy Statement, as follows:

    Votes For
    Votes
    Against
    Abstentions
    Broker Non-Votes
    67,289,18219,578,6881,071,78710,839,908





    SIGNATURE
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
    Dated: June 17, 2025The Beauty Health Company
    By:/s/ Michael Monahan
    Name:Michael Monahan
    Title:Chief Financial Officer

    Get the next $SKIN alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SKIN

    DatePrice TargetRatingAnalyst
    9/19/2025$3.50Buy
    Roth Capital
    11/15/2023$11.00 → $1.50Buy → Hold
    Jefferies
    11/14/2023$10.00 → $2.50Buy → Hold
    Canaccord Genuity
    11/14/2023Neutral → Underweight
    JP Morgan
    11/14/2023$12.00 → $2.00Overweight → Underweight
    Piper Sandler
    11/14/2023$9.00 → $2.50Outperform → Market Perform
    TD Cowen
    11/14/2023Buy → Hold
    The Benchmark Company
    11/14/2023Mkt Perform → Underperform
    Raymond James
    More analyst ratings

    $SKIN
    SEC Filings

    View All

    The Beauty Health Company filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Beauty Health Co (0001818093) (Filer)

    9/30/25 4:32:58 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by The Beauty Health Company

    SCHEDULE 13G/A - Beauty Health Co (0001818093) (Subject)

    9/8/25 9:53:08 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

    8-K - Beauty Health Co (0001818093) (Filer)

    9/4/25 4:28:08 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Hydrafacial Joins Cosmopolitan Readers' Choice Hall of Fame as Three-Time Winner for Best Pro Facial

    LONG BEACH, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that Hydrafacial has been honored with the Cosmopolitan Readers' Choice Award for Best Pro Facial for the third time, solidifying its place in the magazine's prestigious Hall of Fame. The recognition is the latest in a year of industry accolades, further cementing Hydrafacial treatments as the most in-demand professional skincare treatment in the U.S. In 2025 alone, Hydrafacial has been recognized across leading beauty publications and professional communities, including: ELLE Tools & Treatments Awards: Best Hydrating In-Office Treatm

    9/23/25 8:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    MULTIMEDIA UPDATE -- Hydrafacial Launches Inaugural Hydrafacial Advisory Councils & Ambassador Network to Fuel Next-Era Innovation and Growth

    LONG BEACH, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announces the launch of the Hydrafacial Advisory Councils and Ambassador Network – a prestigious collective of plastic surgeons, dermatologists, aesthetic practitioners, and estheticians selected for their expertise and influence in the aesthetic industry. The formation of the Hydrafacial Advisory Councils and Ambassador Network reinforces Hydrafacial's long-standing commitment to its provider community, ensuring the brand's innovation pipeline, education programs, and clinical research remain grounded in real-world insights and excellence in care.

    9/9/25 9:38:56 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Roth Capital initiated coverage on The Beauty Health Company with a new price target

    Roth Capital initiated coverage of The Beauty Health Company with a rating of Buy and set a new price target of $3.50

    9/19/25 8:39:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Jefferies with a new price target

    Jefferies downgraded The Beauty Health Company from Buy to Hold and set a new price target of $1.50 from $11.00 previously

    11/15/23 7:13:27 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company downgraded by Canaccord Genuity with a new price target

    Canaccord Genuity downgraded The Beauty Health Company from Buy to Hold and set a new price target of $2.50 from $10.00 previously

    11/14/23 7:45:38 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Monahan Michael P. covered exercise/tax liability with 32,357 shares, decreasing direct ownership by 2% to 1,326,305 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/12/25 4:17:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Director Gruber Desiree was granted 73,051 shares, increasing direct ownership by 61% to 192,565 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    6/18/25 4:34:50 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Chairman Saunders Brent L was granted 73,051 shares, increasing direct ownership by 1% to 5,994,820 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    6/18/25 4:34:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman Saunders Brent L bought $43,686 worth of shares (40,450 units at $1.08), increasing direct ownership by 0.69% to 5,921,769 units (SEC Form 4)

    4 - Beauty Health Co (0001818093) (Issuer)

    8/13/24 5:00:11 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Leadership Updates

    Live Leadership Updates

    View All

    The Beauty Health Company Names Pedro Malha President and Chief Executive Officer

    Global Healthcare and Medical Device Executive with More Than 20 Years of Experience Assumes Role Effective October 1 Marla Beck Steps Down, With BeautyHealth Prepared for Its Next Phase of Growth LONG BEACH, Calif., Sept. 30, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of Pedro Malha as President and Chief Executive Officer, effective October 1, 2025. He succeeds Marla Beck, who is stepping down as President and CEO effective September 30, 2025, and will remain in an advisory role. Brent Saunders, Chairman of the Board, stated, "Pedro is an accomplished leader with broad industry experience at lea

    9/30/25 4:30:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    The Beauty Health Company Strengthens Commercial Leadership Team with Chief Revenue Officer and Chief Marketing Officer Appointments

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced the appointment of two accomplished industry executives to its commercial leadership team. Ron Menezes will join Beauty Health as Chief Revenue Officer and Carrie Caulkins will join the Company as Chief Marketing Officer, effective October 15, 2024, with both reporting to the Company's Chief Executive Officer, Marla Beck. Mr. Menezes assumes his new role from Dan ("Doc") Watson, who is leaving Beauty Health and will assist with the transition through year-end. Ms. Caulkins fills an open position. Marla Beck commented on the appointments, "We are thrilled to welcome Ron and Carrie to the executive t

    10/15/24 4:10:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Names Sheri Lewis as Chief Supply Chain and Operations Officer

    The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial, today announced that it has appointed Sheri Lewis as Chief Supply Chain and Operations Officer, effective immediately. Ms. Lewis will report to BeautyHealth's President and Chief Executive Officer, Marla Beck. "Sheri is a talented and deeply experienced executive who brings decades of valuable global operations expertise to BeautyHealth as we chart the future of the Company," said Marla Beck, BeautyHealth President and Chief Executive Officer. "The Board of Directors and I are confident that her deep industry experience across global supply chain and operations will play a critical role in advancing our strategic

    4/9/24 4:10:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Financials

    Live finance-specific insights

    View All

    BeautyHealth Reports Second Quarter 2025 Financial Results

    Raises guidance on strong execution and disciplined cost management Advances science-backed innovation with successful launch of the HydraFillic with Pep9™ Booster LONG BEACH, Calif., Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the second quarter ended June 30, 2025 ("Q2 2025"). "Momentum continued to build in the second quarter, as BeautyHealth delivered another strong performance aligned with our strategic transformation goals," said BeautyHealth CEO Marla Beck. "We exceeded revenue and Adjusted EBITDA expectations and raised the full year ou

    8/7/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth to Report Second Quarter 2025 Financial Results on August 7, 2025

    LONG BEACH, Calif., July 24, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN), home to flagship brand Hydrafacial™, today announced it will report second quarter 2025 financial results after market close on Thursday, August 7, 2025. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results. A live webcast of the call can be accessed on the Company's investor relations website at https://investors.beautyhealth.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion. Disclosure InformationThe Beauty Health Company announce

    7/24/25 10:00:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    BeautyHealth Reports First Quarter 2025 Financial Results

    LONG BEACH, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- The Beauty Health Company (NASDAQ:SKIN) ("BeautyHealth" or the "Company"), home to flagship brand Hydrafacial, today announced financial results for the first quarter ended March 31, 2025 ("Q1 2025"). "Our first quarter results reflect strong execution and continued momentum in our transformation strategy," said CEO Marla Beck. "We exceeded both revenue and adjusted EBITDA guidance, driven by gross profit growth and meaningful cost efficiencies. Despite macroeconomic pressures that impacted device sales, consumables revenue remained resilient, reinforcing the strength of our recurring revenue model and sustained consumer dem

    5/8/25 4:05:00 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    $SKIN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 4:16:27 PM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:27:23 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by The Beauty Health Company

    SC 13G/A - Beauty Health Co (0001818093) (Subject)

    11/14/24 11:03:00 AM ET
    $SKIN
    Medical/Dental Instruments
    Health Care